Tumour necrosis factor-αSystemic inflammatory response syndrome: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 1998年 / 731卷 / 1期

关键词：

Melphalan; Systemic Inflammatory Response Syndrome; Liver Perfusion; Capillary Leak; Volume Replacement;

D O I：

10.2165/00128415-199807310-00038

中图分类号：

学科分类号：

摘要：

引用

页码：12 / 12

共 50 条

[21] Tumour necrosis factor-α inhibitors/vedolizumabSpondyloarthropathy: 11 case reports
Reactions Weekly, 2019, 1775 (1) : 442 - 442
[22] Tumour necrosis factor-α inhibitorsPleuropericarditis and lupus: 17 case reports
Reactions Weekly, 2020, 1834 (1) : 246 - 246
[23] Tumour necrosis factor-α inhibitors/immunosuppressantsCancer: 3 case reports
Reactions Weekly, 2012, 1423 (1) : 48 - 48
[24] Tumour necrosis factor-α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab
Pierik, M
Vermeire, S
Steen, KV
Joossens, S
Claessens, G
Vlietinck, R
Rutgeerts, P
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (03) : 303 - 310
[25] BMI is important in predicting the loss of response in inflammatory bowel disease patients on tumour necrosis factor-α inhibitors
Chuck, Winnie
Shadbolt, Bruce Frederick
Nordin, Fariza
Subramaniam, Kavitha
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (06) : 622 - 629
[26] Endometriosis is sustained by tumour necrosis factor-α
Bullimore, DW
MEDICAL HYPOTHESES, 2003, 60 (01) : 84 - 88
[27] Safety of tumour necrosis factor-α antagonists
Khanna, D
McMahon, M
Furst, DE
DRUG SAFETY, 2004, 27 (05) : 307 - 324
[28] Safety of Tumour Necrosis Factor-α Antagonists
Dinesh Khanna
Maureen McMahon
Daniel E. Furst
Drug Safety, 2004, 27 : 307 - 324
[29] Tumour necrosis factor-α and selectins are not useful as inflammatory markers in acute coronary syndromes
Lindner, K
Nauck, M
März, W
Winkler, R
Klein, B
Gök, R
Taubert, G
Winkelmann, BR
EUROPEAN HEART JOURNAL, 2000, 21 : 658 - 658
[30] Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-α by inhibiting nuclear factor-κB activation
Posadas, I
De Rosa, S
Terencio, MC
Payá, M
Alcaraz, MJ
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (08) : 1571 - 1579

← 1 2 3 4 5 →